MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Clinical trial NCT06434376 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06434376
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.